Your browser doesn't support javascript.
loading
Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
Imamura, Fumiaki; Fretts, Amanda M; Marklund, Matti; Ardisson Korat, Andres V; Yang, Wei-Sin; Lankinen, Maria; Qureshi, Waqas; Helmer, Catherine; Chen, Tzu-An; Virtanen, Jyrki K; Wong, Kerry; Bassett, Julie K; Murphy, Rachel; Tintle, Nathan; Yu, Chaoyu Ian; Brouwer, Ingeborg A; Chien, Kuo-Liong; Chen, Yun-Yu; Wood, Alexis C; Del Gobbo, Liana C; Djousse, Luc; Geleijnse, Johanna M; Giles, Graham G; de Goede, Janette; Gudnason, Vilmundur; Harris, William S; Hodge, Allison; Hu, Frank; Koulman, Albert; Laakso, Markku; Lind, Lars; Lin, Hung-Ju; McKnight, Barbara; Rajaobelina, Kalina; Riserus, Ulf; Robinson, Jennifer G; Samieri, Cecilia; Senn, Mackenzie; Siscovick, David S; Soedamah-Muthu, Sabita S; Sotoodehnia, Nona; Sun, Qi; Tsai, Michael Y; Tuomainen, Tomi-Pekka; Uusitupa, Matti; Wagenknecht, Lynne E; Wareham, Nick J; Wu, Jason H Y; Micha, Renata; Lemaitre, Rozenn N.
Afiliação
  • Imamura F; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Fretts AM; Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
  • Marklund M; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
  • Ardisson Korat AV; The George Institute for Global Health, the Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Yang WS; Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts, United States of America.
  • Lankinen M; Department of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Qureshi W; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Helmer C; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, the Republic of China.
  • Chen TA; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
  • Virtanen JK; Section of Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
  • Wong K; INSERM, UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.
  • Bassett JK; USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Murphy R; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
  • Tintle N; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
  • Yu CI; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
  • Brouwer IA; Centre of Excellence in Cancer Prevention, School of Population & Public Health, Faculty of Medicine, The University of British Columbia, Vancouver, Canada.
  • Chien KL; Department of Mathematics and Statistics, Dordt University, Sioux Center, Iowa, United States of America.
  • Chen YY; Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington, United States of America.
  • Wood AC; Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Del Gobbo LC; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, the Republic of China.
  • Djousse L; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, the Republic of China.
  • Geleijnse JM; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei City, the Republic of China.
  • Giles GG; USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.
  • de Goede J; Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, United States of America.
  • Gudnason V; Divisions of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Harris WS; Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.
  • Hodge A; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
  • Hu F; Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Australia.
  • Koulman A; Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.
  • Laakso M; Icelandic Heart Association Research Institute, Kopavogur, Iceland.
  • Lind L; Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota, United States of America.
  • Lin HJ; OmegaQuant Analytics, Sioux Falls, South Dakota, United States of America.
  • McKnight B; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
  • Rajaobelina K; Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Australia.
  • Riserus U; Department of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Robinson JG; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Senn M; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Siscovick DS; National Institute for Health Research Biomedical Research Centres Core Nutritional Biomarker Laboratory, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Soedamah-Muthu SS; National Institute for Health Research Biomedical Research Centres Core Metabolomics and Lipidomics Laboratory, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Sotoodehnia N; Medical Research Council Elsie Widdowson Laboratory, Cambridge, United Kingdom.
  • Sun Q; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland.
  • Tsai MY; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
  • Tuomainen TP; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Uusitupa M; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, the Republic of China.
  • Wagenknecht LE; Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington, United States of America.
  • Wareham NJ; INSERM, UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.
  • Wu JHY; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
  • Micha R; Preventive Intervention Center, Departments of Epidemiology, the University of Iowa College of Public Health, Iowa City, Iowa, United States of America.
  • Lemaitre RN; INSERM, UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.
PLoS Med ; 17(6): e1003102, 2020 06.
Article em En | MEDLINE | ID: mdl-32530938
ABSTRACT

BACKGROUND:

De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (160, 161n7, 180, 181n9) in DNL with incidence of type 2 diabetes (T2D). METHODS AND

FINDINGS:

Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970-1973 to 2006-2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%-62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 160, 161n7, 180, and 181n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-variance-weighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41-1.66; p < 0.001) for 160, 1.40 (1.33-1.48; p < 0.001) for 161n-7, 1.14 (1.05-1.22; p = 0.001) for 180, and 1.16 (1.07-1.25; p < 0.001) for 181n9. Heterogeneity was seen across cohorts (I2 = 51.1%-73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 160 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 160, 161n7, and 180 but were attenuated for 181n9 (RR = 1.03, 95% confidence interval (CI) = 0.94-1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors.

CONCLUSIONS:

Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Lipogênese / Ácidos Graxos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Lipogênese / Ácidos Graxos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido